Inventor
WALLACH DAVID
IL71 patents
⚠️ This page may combine multiple inventors who share the name “WALLACH DAVID”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
YEDA RES & DEV
41 patentsUS5478925ADec 26, 1995
Multimers of the soluble forms of TNF receptors, their preparation and pharmaceutical compositions containing them
YEDA RES & DEV209 citations98
US5695953ADec 9, 1997
DNA that encodes a tumor necrosis factor inhibitory protein and a recombinant method of production
YEDA RES & DEV54 citations96
US5621077AApr 15, 1997
Soluble IFN-β2/IL-6 binding protein its preparation, and pharmaceutical compositions containing it
YEDA RES & DEV90 citations95
US5359037AOct 25, 1994
Antibodies to TNF binding protein I
YEDA RES & DEV82 citations95
US5216128AJun 1, 1993
IFN-β2/IL-6 receptor its preparation and pharmaceutical compositions containing it
YEDA RES & DEV55 citations95
US5512544AApr 30, 1996
Pharmaceutical compositions comprising an anticytokine
YEDA RES & DEV117 citations94
US6579697B1Jun 17, 2003
Modulator of TNF/NGF superfamily receptors and soluble oligomeric TNF/NGF superfamily receptors
YEDA RES & DEV32 citations92
US5981701ANov 9, 1999
Tumor necrosis factor inhibitory protein and its purification
YEDA RES & DEV20 citations92
US6602993B2Aug 5, 2003
DNA molecule encoding TNF binding ligands and vectors and host cells containing the DNA molecule
YEDA RES & DEV19 citations91
US6555111B2Apr 29, 2003
Method of inhibiting the cytocidal effect of TNF with TNF receptor-specific antibodies
YEDA RES & DEV16 citations91
US6262239B1Jul 17, 2001
TNF receptor-specific antibodies
YEDA RES & DEV29 citations91
US6232446B1May 15, 2001
TNF ligands
YEDA RES & DEV33 citations91
US6083534AJul 4, 2000
Pharmaceutical compositions for controlled release of soluble receptors
YEDA RES & DEV77 citations91
US5811261ASep 22, 1998
Expression of the recombinant tumor necrosis factor binding protein I (TBP-I)
YEDA RES & DEV34 citations90
US5665859ASep 9, 1997
Molecules influencing the shedding of the TNF receptor, their preparation and their use
YEDA RES & DEV35 citations90
US7101675B2Sep 5, 2006
Modulators of regulatory proteins
YEDA RES & DEV18 citations88
US6090923AJul 18, 2000
Murine monoclonal antibody binding TNFα
YEDA RES & DEV26 citations88
US8362206B2Jan 29, 2013
Chimeric proteins and uses thereof
YEDA RES & DEV22 citations86
US5211945AMay 18, 1993
Compositions and methods for modulating the effect of tnf and il-1
YEDA RES & DEV18 citations80
US4622292ANov 11, 1986
Assay and kit for determining interferon
YEDA RES & DEV11 citations74
US6479632B1Nov 12, 2002
Tumor necrosis factor inhibitory protein and its purification
YEDA RES & DEV9 citations73
US7485456B1Feb 3, 2009
Modulators of TNF receptor associated factor (TRAF), their preparation and use
YEDA RES & DEV6 citations71
US5795975AAug 18, 1998
TNF receptor promoter
YEDA RES & DEV8 citations71
US5766917AJun 16, 1998
Method for identifying and producing a protease capable of cleaving the TNF receptor
YEDA RES & DEV13 citations71
US5959094ASep 28, 1999
p75 TNF receptor promoters
YEDA RES & DEV7 citations68
US7429379B2Sep 30, 2008
TNF receptor action modulation
YEDA RES & DEV3 citations62
US7186682B2Mar 6, 2007
Modulator of TNF/NGF superfamily receptors and soluble oligomeric TNF/NGF superfamily receptors
YEDA RES & DEV4 citations62
US7056505B2Jun 6, 2006
TNF receptor action modulation
YEDA RES & DEV2 citations62
US6395267B1May 28, 2002
TNF receptor action modulation
YEDA RES & DEV3 citations62
US7189535B2Mar 13, 2007
Modulators of the function of receptors of the TNF/NGF receptor family and other proteins
YEDA RES & DEV2 citations61
US7083788B2Aug 1, 2006
Modulators of the function of receptors of the TNF/NGF receptor family and other proteins
YEDA RES & DEV2 citations61
US6586571B1Jul 1, 2003
Modulators of the function of FAS receptors and other proteins
YEDA RES & DEV3 citations59
US6399327B1Jun 4, 2002
Modulators of the function of FAS receptors and other proteins
YEDA RES & DEV4 citations59
US6734174B1May 11, 2004
Modulators of the function of receptors of the TNF/NGF receptor
YEDA RES & DEV5 citations58
US6355780B1Mar 12, 2002
Antibodies to the death domain motifs of regulatory proteins
YEDA RES & DEV2 citations58
US5462731AOct 31, 1995
Use of IL-6 for the treatment of chronic lymphocyte leukemia (CLL) and B-cell lymphomas
YEDA RES & DEV4 citations58
US4302533ANov 24, 1981
Novel assays for interferon
YEDA RES & DEV5 citations58
US7429648B1Sep 30, 2008
IREN protein, its preparation and use
YEDA RES & DEV5 citations54
US8383781B2Feb 26, 2013
Anti-NIK antibodies and uses thereof
YEDA RES & DEV0 citations51
US7728111B2Jun 1, 2010
Anti-p55 TNF receptor antibody
YEDA RES & DEV0 citations51
US7455977B2Nov 25, 2008
Methods of determining the level of human TBP-II with anti-TBP-II antibody
YEDA RES & DEV0 citations51
IBM
5 patentsUS6038630AMar 14, 2000
Shared access control device for integrated system with multiple functional units accessing external structures over multiple data buses
IBM270 citations98
US7111266B2Sep 19, 2006
Multiple voltage integrated circuit and design method therefor
IBM23 citations92
US6323755B1Nov 27, 2001
Dynamic bus locking in a cross bar switch
IBM24 citations92
US6275890B1Aug 14, 2001
Low latency data path in a cross-bar switch providing dynamically prioritized bus arbitration
IBM35 citations92
US7480883B2Jan 20, 2009
Multiple voltage integrated circuit and design method therefor
IBM9 citations83
WALLACH DAVID
3 patentsUS8092806B2Jan 10, 2012
Chimeric proteins, their preparation and pharmaceutical compositions containing them
WALLACH DAVID9 citations80
US8236507B2Aug 7, 2012
Modulators of TNF receptor associated factor (TRAF), their preparation and use
WALLACH DAVID2 citations60
US8138323B2Mar 20, 2012
Isolated cDNA encoding tumor necrosis factor binding protein II, its purification, and vectors, hosts and processes using such cDNA
WALLACH DAVID0 citations51
BOYKO DANIEL
1 patentShowing the top 50 of 71 patents by PatentIndex Score.